Epileptiform activity of veratridine model in rat brain slices: Effects of antiepileptic drugs

Epilepsy Research

Volumn 38, Issue 2-3, 2000, Pages 161-170

  Otoom, Sameer A ^a   Alkadhi, Karim A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Epileptiform activity; Ethosuximide; Hippocampus; Phenytoin; Spontaneous bursting; Valproic acid; Veratridine

Indexed keywords

ANTICONVULSIVE AGENT; ETHOSUXIMIDE; PHENYTOIN; SODIUM; SODIUM CHANNEL; VALPROIC ACID; VERATRIDINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EPILEPTIC DISCHARGE; HIPPOCAMPUS; NONHUMAN; PRIORITY JOURNAL; RAT;

ACTION POTENTIALS; ANIMALS; ANTICONVULSANTS; CONVULSANTS; ETHOSUXIMIDE; HIPPOCAMPUS; ION CHANNEL GATING; ION TRANSPORT; PHENYTOIN; PYRAMIDAL CELLS; RATS; SODIUM; SODIUM CHANNELS; VALPROIC ACID; VERATRIDINE;

EID: 0033992309     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(99)00084-4     Document Type: Article

References (42)

1. Albus H., Williamson R. Electrophysiologic analysis of the actions of valproate on pyramidal neurons in the rat hippocampal slice. Epilepsia. 39:1998;124-139.
2. Alkadhi K.A., Banks F.W. Pre- and postsynaptic actions of valproic acid at the frog neuromuscular junction. Brain Res. 306:1984;388-390.
3. Alkadhi K.A., Tian L.M. Veratridine-enhanced persistent sodium current induces bursting in CA1 pyramidal neurons. Neuroscience. 71:1996;625-632.
4. Altrup U., Reith H., Speckmann E.J. Effects of valproate in a model nervous system (buccal ganglia of Helix pomatia): II: epileptogenic actions. Epilepsia. 33:1992;753-759.
5. Apatoff B.R., Riker W.K. Effects of the anticonvulsant dipropylacetate on bullfrog sympathetic ganglia. Proc. West Pharmacol. Soc. 23:1980;151-156.
6. Armand V., Louvel J., Pumain R., Ronco G., Villa P. Effects of various valproic acid derivatives on low-calcium spontaneous epileptiform activity in hippocampal slices. Epilepsy Res. 22:1995;185-192.
7. Ayala G.F., Lin S., Johnston D. The mechanism of action of diphenylhydantoin or invertebrate neurons: I: effects on basic membrane properties. Brain Res. 121:1977;245-258.
8. Buchhalter J.R., Dichter M.A. Effects of valproic acid in cultured mammalian neurons. Neurology. 36:1986;259-262.
9. Chapman A., Keane P.E., Meldrum B.S., Simiand J., Vernieres J.C. Mechanism of anticonvulsant action of valproate. Prog. Neurobiol. 19:1982;315-359.
10. Cotariu D., Zaidman J.L., Evans S. Neurophysiological and biochemical changes evoked by valproic acid in the central nervous system. Prog. Neurobiol. 34:1990;343-354.
11. Coulter D.A. Antiepileptic drug cellular mechanisms of action: where does lamotrigine fit in? J. Child. Neurol. 12:1997;S2-S9.
12. Coulter D.A., Huguenard J.R., Prince D.A. Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons. Ann. Neurol. 25:1989;582-593.
13. Courtney K.R., Etter E.F. Modulated anticonvulsant block of sodium channels in nerve and muscle. Eur. J. Pharmacol. 88:1983;1-9.
14. Ehle A.L. Effects of phenytoin on amygdaloid kindled seizures in the rat. Electroencephalogr. Clin. Neurophysiol. 48:1980;102-105.
15. Fohlmeister J.F., Adelman W.J. Jr, Brennan J.J. Excitable channel currents and gating times in the presence of anticonvulsants ethosuximide and valproate. J. Pharmacol. Exp. Ther. 230:1984;75-81.
16. Fromm G.H., Glass J.D., Chattha A.S., Martinez A.J. Effect of anticonvulsant drugs on inhibitory and excitatory pathways. Epilepsia. 22:1981;65-73.
17. Giroud M., Dumas R. Treatment of status epilepticus by sodium valproate. Neurophysiol. Clin. 18:1988;21-32.
18. Heinemann U., Franceschetti S., Hamon B., Konnerth A., Yaari Y. Effects of anticonvulsants on spontaneous epileptiform activity which develops in the absence of chemical synaptic transmission in hippocampal slices. Brain Res. 325:1985;349-352.
19. Hille B. Modifiers of gating. Ionic Channels of Excitable Membranes. 1992;445-470 Sinauer Associates, Sunderland, MA.
20. Kelly K.M., Gross R.A., Macdonald R.L. Valproic acid selectively reduces the low-threshold (T) calcium current in rat nodose neurons. Neurosci. Lett. 116:1990;233-238.
21. Macdonald R.L. Is there a mechanistic basis for rational polypharmacy? Epileps. Res. 11 (Suppl.):1996;79-93.
22. Macdonald R.L., Kelly K.M. Mechanisms of action of currently prescribed and newly developed antiepileptic drugs. Epilepsia. 35:1994;S41-S50.
23. McLean M.J., Macdonald R.L. Multiple actions of phenytoin on mouse spinal cord neurons in cell culture. J. Pharmacol. Exp. Ther. 227:1983;779-789.
24. McLean M.J., Macdonald R.L. Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture. J. Pharmacol. Exp. Ther. 237:1986;1001-1011.
25. Nosek T.M. How valproate and phenytoin affect the ionic conductances and active transport characteristics of the crayfish giant axon. Epilepsia. 22:1981;651-665.
26. Oguni H., Uehara T., Tanaka T., Sunahara M., Hara M., Osawa M. Dramatic effect of ethosuximide on epileptic negative myoclonus: implications for the neurophysiological mechanism. Neuropediatrics. 29:1998;29-34.
27. Otoom S., Tian L.M., Alkadhi K.A. Veratridine-treated brain slices: a cellular model for epileptiform activity. Brain Res. 789:1998;150-156.
28. Otoom, S.A., Alkadhi, K.A., 1999. Valproic acid intensifies epileptiform activity in the hippocampal pyramidal neurons. Neurosci. Res. (in press).
29. Parks B.R. Jr, Dostrow V.G., Noble S.L. Drug therapy for epilepsy. Am. Fam. Physician. 50:1994;634-653.
30. Perreault P., Tancredi V., Avoli M. Failure of the antiepileptic drug valproic acid to modify synaptic and non-synaptic responses of CA1 hippocampal pyramidal cells maintained 'in vitro'. Epilepsy Res. 3:1989;227-231.
31. Rafiq A., Zhang Y.F., DeLorenzo R.J., Coulter D.A. Long-duration self-sustained epileptiform activity in the hippocampal-parahippocampal slice: a model of status epilepticus. J. Neurophysiol. 74:1995;2028-2042.
32. Rogawski M.A. Mechanism-specific pathways for new antiepileptic drug discovery. Adv. Neurol. 76:1998;11-27.
33. Schneiderman J.H., Evans J.C. Effects of anticonvulsants on penicillin-induced bursting in guinea pig hippocampal slices. Epilepsia. 27:1986;347-353.
34. Selzer M.E. The effect of phenytoin on the action potential of a vertebrate spinal neuron. Brain Res. 171:1979;511-521.
35. Slater G.E., Johnston D. Sodium valproate increases potassium conductance in Aplysia neurons. Epilepsia. 19:1978;379-384.
36. Swinyard E.A., Woodhead J.H. Experimental detection, quantification and evaluation of antiepileptic drugs. Woodbury D.M., Penry J.K., Pippenger C.E. Antiepileptic Drugs. 1982;111-126 Raven Press, New York.
37. 2+-conducting channels in isolated rat hippocampal CA1 neurons. Neurosci. Lett. 148:1992;60-62.
38. Tian L.M., Otoom S., Alkadhi K.A. Endogenous bursting due to altered sodium channel function in rat hippocampal CA1 neurons. Brain Res. 680:1995;164-172.
39. Van den Berg R.J., Kok P., Voskuyl R.A. Valproate and sodium currents in cultured hippocampal neurons. Exp. Brain Res. 93:1993;279-287.
40. Wallace S.J. Use of ethosuximide and valproate in the treatment of epilepsy. Neurol. Clin. 4:1986;601-616.
41. Wilbur R., Kulik F.A. Anticonvulsant drugs in alcohol withdrawal: use of phenytoin, primidone, carbamazepine, valproic acid, and the sedative anticonvulsants. Am. J. Hosp. Pharm. 38:1981;1138-1143.
42. Zona C., Avoli M. Effects induced by the antiepileptic drug valproic acid upon the ionic currents recorded in rat neocortical neurons in cell culture. Exp. Brain Res. 81:1990;313-317.